| Home > Publications database > Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease. > Access to Fulltext |
1-s2.0-S2950328026000117-main-1
|
|||||||
| version 1 |
| ||||||